Elite Pharmaceuticals, Inc. (ELTP)
0.461
-0.01
(-1.82%)
USD |
OTCM |
Jan 20, 15:16
Elite Pharmaceuticals Market Cap: 495.34M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 835.45M |
| Palatin Technologies, Inc. | 14.87M |
| Theriva Biologics, Inc. | 6.077M |
| Oragenics, Inc. | 0.7818M |
| NanoViricides, Inc. | 20.52M |
Market Cap Related Metrics
| PE Ratio | 82.32 |
| PS Ratio | 4.076 |
| Price to Book Value | 8.043 |
| Price to Free Cash Flow | 23.13 |
| Price | 0.461 |
| Earnings Yield | 1.21% |
| Operating PE Ratio | 11.45 |
| Normalized PE Ratio | 24.52 |